PLA2G6 antibody
Principal name
PLA2G6 antibody
Alternative names for PLA2G6 antibody
IPLA2, Cal-PLA2, GVI PLA2, Group VI phospholipase A2, PARK14, 85 kDa calcium-independent phospholipase A2
Ncbi ID
9606, NP_001004426, NP_001004426.1, NM_001004426, NM_003560, NP_003551, NP_001185952.1, NM_016915
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P), Immunoprecipitation (IP), Frozen Sections (C)
Background of PLA2G6 antibody
- Kit Component:
- - KN313395G1, Pla2g6 gRNA vector 1 in pCas-Guide vector
- KN313395G2, Pla2g6 gRNA vector 2 in pCas-Guide vector
- KN313395D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ayilavarapu, S., et al. J. Immunol. 184(3): 1507-1515 (2010)
Guey, L.T., et al. Eur. Urol. 57(2): 283-292 (2010)
Tan, E.K., et al. Ann. Neurol. 67 (1): 148 (2010)
Hosgood, H.D. III, et al. Respir Med 103(12): 1866-1870 (2009)
Western Blot analysis of PLA2G6 expression in transfected 293T cell line (H00008398-T01) by PLA2G6 MaxPab polyclonal antibody.Lane 1: PLA2G6 transfected lysate(82.72 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of PLA2G6 expression in transfected 293T cell line (H00008398-T01) by PLA2G6 MaxPab polyclonal antibody.Lane 1: PLA2G6 transfected lysate(82.72 KDa).Lane 2: Non-transfected lysate.
PLA2G6 MaxPab rabbit polyclonal antibody. Western Blot analysis of PLA2G6 expression in mouse kidney.
PLA2G6 MaxPab rabbit polyclonal antibody. Western Blot analysis of PLA2G6 expression in human kidney.
Western Blot analysis of PLA2G6 expression in transfected 293T cell line (H00008398-T01) by PLA2G6 MaxPab polyclonal antibody.Lane 1: PLA2G6 transfected lysate(84.10 KDa).Lane 2: Non-transfected lysate.
Immunohistochemistry analysis in testis carcinoma (Formalin-fixed, Paraffin-embedded) using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by peroxidase conjugated secondary antibody and DAB staining. This data demonstrates the use of the PLA2G6 antibody for IHC. Clinical relevance has not been evaluated.
Confocal immunofluorescent analysis with HepG2 cell using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by Alexa Fluor® 488-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
Western blot analysis of PLA2G6 (arrow) in HepG2 cell line lysates (35ug/lane) using PLA2G6 antibody Cat.-No. AP53326PU-N.
Flow cytometric analysis of HepG2 cells (right histogram) compared to a negative control cell (left histogram) using PLA2G6 antibody Cat.-No. AP53326PU-N, followed by FITC-conjugated goat-anti-rabbit secondary antibodies.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PLA2G6 (RC208735, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PLA2G6.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PLA2G6 (RC208735, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PLA2G6.
Western blot analysis of extracts from HeLa cells, using PA2G6 antibody.The lane on the right is treated with the synthesized peptide.
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP53326PU-N | PLA2G6 (Center) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | F, ICC/IF, P, WB |
0.4 ml /
€370.00
|
|
| Acris Antibodies GmbH | |||||||
 +3 additional images |
Highly validated antibody! |
||||||
| TA314745 | PLA2G6 antibody |
||||||
| Rabbit polyclonal anti-PA2G6 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€325.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA351027 | PLA2G6 antibody |
||||||
| Rabbit Polyclonal Anti-PLA2G6 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€325.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA803175 | PLA2G6 antibody |
||||||
| PLA2G6 mouse monoclonal antibody, clone OTI10G4 (formerly 10G4) | |||||||
 |
Mouse | IgG1 | OTI10G4 | Purified | Hu | WB |
0.1 ml /
€325.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA803198 | PLA2G6 antibody |
||||||
| PLA2G6 mouse monoclonal antibody, clone OTI10A2 (formerly 10A2) | |||||||
 |
Mouse | IgG2a | OTI10A2 | Purified | Hu | WB |
0.1 ml /
€325.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| AP55152SU-N | PLA2G6 antibody |
||||||
|
Rabbit | Serum | Hu | C, E, WB |
0.2 ml /
€400.00
|
||
| Acris Antibodies GmbH | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN313395 | Pla2g6 - mouse gene knockout kit via CRISPR |
||
|
Mouse | GFP-Puro |
1 kit /
€1,200.00
|
| OriGene Technologies, Inc. | |||
| KN313395BN | Pla2g6 - mouse gene knockout kit via CRISPR |
||
|
Mouse | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN313395LP | Pla2g6 - mouse gene knockout kit via CRISPR |
||
|
Mouse | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN313395RB | Pla2g6 - mouse gene knockout kit via CRISPR |
||
|
Mouse | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP307546 | PLA2G6 (transcript variant 1) |
||||
| Recombinant protein of human phospholipase A2, group VI (cytosolic, calcium-independent) (PLA2G6), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| TP308735 | PLA2G6 (transcript variant 2) |
||||
| Recombinant protein of human phospholipase A2, group VI (cytosolic, calcium-independent) (PLA2G6), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY400377 | PLA2G6 overexpression lysate |
|
|
0.1 mg /
€280.00
|
|
| OriGene Technologies, Inc. | ||
| LY418601 | PLA2G6 overexpression lysate |
|
|
0.1 mg /
€280.00
|
|
| OriGene Technologies, Inc. | ||
| LY429150 | PLA2G6 overexpression lysate |
|
|
0.1 mg /
€480.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210470L2V | Lenti ORF particles, Pla2g6 (GFP-tagged) - Mouse phospholipase A2, group VI (Pla2g6), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,450.00
|
|
| OriGene Technologies, Inc. | ||
| MR210470L1V | Lenti ORF particles, Pla2g6 (Myc-DDK-tagged) - Mouse phospholipase A2, group VI (Pla2g6), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,300.00
|
|
| OriGene Technologies, Inc. | ||
